Investors

Financial results and information

Beamtree’s products and services have created value and helped solve global healthcare problems using data, insight and pioneering technology for more than two decades. Find out more about our company below, including our latest annual reports and investor presentations.

Learn more about Beamtree

Reports

  • Beamtree Interim Report FY24

  • Beamtree Annual Report 2023

  • Beamtree Interim Report FY23

  • Beamtree Annual Report 2022

  • Beamtree Half Year Report 2022

  • Beamtree Annual Report 2021

  • PKS Annual Report 2020

  • PKS Annual Report 2019

ASX Releases

Date

  • 1H FY24 Investor Webinar Record

    15 February 2024

  • 1H FY24 Results and Trading Update

    14 February 2024

  • 1H FY24 Investor Presentation

    14 February 2024

  • Appendix 4D and FY24 Interim Report

    14 February 2024

  • Beamtree 1H FY24 Results and Investor Webinar

    25 January 2024

  • Change in substantial holding from MIR

    25 January 2024

  • Application for quotation of securities - BMT

    16 January 2024

  • Final Director's Interest Notice - S Borness

    4 January 2024

  • Resignation of Non-Executive Director - Stephen Borness

    2 January 2024

  • Change of Director's Interest Notice - B Lancken

    22 December 2023

  • Change of Director's Interest Notice - J Birch

    22 December 2023

  • Change of Director's Interest Notice - E Gray

    22 December 2023

  • Cleansing Notice

    22 December 2023

  • Application for quotation of securities - BMT

    22 December 2023

  • Application for quotation of securities - BMT

    22 December 2023

  • Product Demonstration Webinar Recording

    22 November 2023

  • Results of Annual General Meeting

    21 November 2023

  • Annual General Meeting Addresses and Presentation

    21 November 2023

  • Product Demonstration - updated link

    20 November 2023

  • Issue of Performance Rights to Executives

    17 November 2023

  • Notification regarding unquoted securities - BMT

    17 November 2023

  • Notification regarding unquoted securities - BMT

    17 November 2023

  • Beamtree AGM Product Demonstration

    15 November 2023

  • Application for quotation of securities

    31 October 2023

  • Application for quotation of securities

    31 October 2023

  • Cleansing Notice

    31 October 2023

  • Q1 FY24 Trading Update

    27 October 2023

  • Notice of Annual General Meeting/Proxy Form

    20 October 2023

  • Application for quotation of securities

    12 October 2023

  • Application for quotation of securities

    28 September 2023

  • Change of Director's Interest Notice - M Hill

    5 September 2023

  • FY23 Investor Webinar Record

    29 August 2023

  • Cleansing Notice

    28 August 2023

  • Application for quotation of securities

    28 August 2023

  • FY23 Results Announcement

    24 August 2023

  • FY23 Investor Presentation

    24 August 2023

  • Appendix 4G and Corporate Governance Statement

    24 August 2023

  • FY23 Annual Report

    24 August 2023

  • Preliminary Final Report

    24 August 2023

  • Beamtree Full Year Results and Investor Webinar

    16 August 2023

  • Q4 FY23 Trading Update

    27 July 2023

  • Application for quotation of securities

    13 July 2023

  • Cleansing Notice

    6 July 2023

  • Application for quotation of securities

    6 July 2023

  • Cleansing Notice

    26 June 2023

  • Application for quotation of securities

    26 June 2023

  • Change in substantial holding

    23 June 2023

  • Application for quotation of securities

    8 June 2023

  • Beamtree secures first contract in Canada

    8 June 2023

  • Application for quotation of securities - BMT

    6 June 2023

  • Cleansing Notice

    6 June 2023

  • Proposed issue of securities - BMT

    29 May 2023

  • Beamtree completes $5m capital raise

    29 May 2023

  • Trading Halt

    25 May 2023

  • Application for quotation of securities - BMT

    28 April 2023

  • Q3 FY23 Trading Update Presentation

    27 April 2023

  • Q3 FY23 Trading Update

    27 April 2023

  • Cleansing Notice

    20 March 2023

  • Application for quotation of securities - BMT

    20 March 2023

  • Application for quotation of securities - BMT

    15 March 2023

  • Change of Director's Interest Notice - M Hill

    10 March 2023

  • 1H FY23 Investor Webinar Record

    16 February 2023

  • 1H FY23 Trading Highlights

    15 February 2023

  • Appendix 4D and FY23 Interim Report

    15 February 2023

  • 1H FY23 Investor Presentation

    15 February 2023

  • Beamtree 1H FY23 Results and Investor Webinar

    1 February 2023

  • BMT agrees revised contract terms Health Roundtable Limited

    31 January 2023

  • Notification regarding unquoted securities - BMT

    24 January 2023

  • Clarification of contract with Abbott

    16 December 2022

  • Beamtree agrees new global contract with Abbott

    16 December 2022

  • Initial Director's Interest Notice - E Gray

    30 November 2022

  • Final Director's Interest Notice - P Williams

    30 November 2022

  • Final Director's Interest Notice - A Gray

    30 November 2022

  • Annual General Meeting Webinar Record

    29 November 2022

  • Amended Constitution

    25 November 2022

  • Results of Annual General Meeting

    24 November 2022

  • Annual General Meeting Addresses and Presentation

    24 November 2022

  • Annual General Meeting Webinar

    23 November 2022

  • Beamtree Trading Update

    31 October 2022

  • Notice of Annual General Meeting Proxy Form

    25 October 2022

  • Change of Director's Interest Notice

    21 October 2022

  • Cleansing Notice

    20 October 2022

  • Application for quotation of securities

    20 October 2022

  • Notification regarding unquoted securities

    20 October 2022

  • Beamtree announces partnership in Kingdom of Saudi Arabia

    11 October 2022

  • Appointment to Beamtree Board Mrs Emma Gray

    5 October 2022

  • Notification of cessation of securities - BMT

    30 September 2022

  • Change of Director's Interest Notice - M Hill

    21 September 2022

  • Notice under ASX Listing Rule 3.10A

    21 September 2022

  • Notification of cessation of securities - BMT

    1 September 2022

  • Change of Director's Interest Notice - M Hill

    29 August 2022

  • FY22 Results Announcement

    24 August 2022

  • FY22 Investor Presentation

    24 August 2022

  • Appendix 4G and Corporate Governance Statement

    24 August 2022

  • FY22 Annual Report

    24 August 2022

  • Preliminary Final Report

    24 August 2022

  • Beamtree Full Year Results and Investor Webinar

    10 August 2022

  • Beamtree Trading Update

    29 July 2022

  • Confirmation of Capital Structure

    20 July 2022

  • Cleansing Notice

    20 July 2022

  • Application for quotation of securities - BMT

    20 July 2022

  • Application for quotation of securities - BMT

    20 July 2022

  • Change of Director's Interest Notice - S Borness

    1 July 2022

  • Notice under ASX Listing Rule 3.10A

    31 May 2022

  • BMT Business Update Presentation

    17 May 2022

  • BMT Business Update

    17 May 2022

  • BMT signs USD$7M 5-year contract for RippleDown Diagnostics

    10 May 2022

  • Beamtree confirms key renewal

    30 March 2022

  • Beamtree accelerates international growth with first NHS contracts

    22 March 2022

  • Investor Presentation 1HY results and growth strategy focus

    1 March 2022

  • Beamtree appoints Mark McLellan as new Chief Financial Officer

    24 February 2022

  • Beamtree 1H FY22 business update and financials

    15 February 2022

  • 1H FY22 Investor Webinar

    10 February 2022

  • Change of Director's Interest Notice - A Gray

    29 November 2021

  • Change of Director's Interest Notice - M Hill

    23 November 2021

  • Change of Director's Interest Notice - S Borness

    10 November 2021

  • JobKeeper Payment Disclosure

    10 November 2021

  • Results of Annual General Meeting

    28 October 2021

  • Investor Presentation to the AGM

    28 October 2021

  • Chairman and CEO Address to the AGM

    28 October 2021

  • Cleansing Notice

    14 October 2021

  • Application for quotation of securities - BMT

    14 October 2021

  • Cleansing Notice

    7 October 2021

  • Application for quotation of securities - BMT

    7 October 2021

  • Clarification Statement - CALHN Strategic Partnership

    1 October 2021

  • Completion of Acquisition of Potential(x)

    30 September 2021

  • Cleansing Notice

    30 September 2021

  • Notification regarding unquoted securities - BMT

    30 September 2021

  • Application for quotation of securities - BMT

    30 September 2021

  • BMT and CALHN partner to pioneer AI for safer patient care

    30 September 2021

  • Notice of Annual General Meeting and Proxy Form

    27 September 2021

  • Change of Director's Interest Notice - S Borness

    22 September 2021

  • Change of Director's Interest Notice - M Hill

    21 September 2021

  • Ceasing to be a substantial holder

    10 September 2021

  • Change of Director's Interest Notice - J Birch

    10 September 2021

  • Notification of cessation of securities - BMT

    7 September 2021

  • Change of Director's Interest Notice - A Gray

    7 September 2021

  • Change of Director's Interest Notice - J Birch

    7 September 2021

  • Cleansing Notice

    2 September 2021

  • Application for quotation of securities - BMT

    2 September 2021

  • Ceasing to be a substantial holder

    1 September 2021

  • Application for quotation of securities - BMT

    31 August 2021

  • Beamtree acquisition presentation

    30 August 2021

  • Proposed issue of securities - BMT

    30 August 2021

  • Beamtree acquires Potential (x)

    30 August 2021

  • Record FY21 results delivers sustainable growth

    27 August 2021

  • Investor Webinar Notification

    27 August 2021

  • Trading Halt

    27 August 2021

  • Appendix 4G and Corporate Governance Statement

    27 August 2021

  • Investor Presentation Financial Year 2021

    27 August 2021

  • 2021 Annual Report

    27 August 2021

  • Preliminary Final Report

    27 August 2021

  • Collaboration to Accelerate Global Health Research

    25 August 2021

  • Change of Company Name and ASX Ticker

    18 August 2021

  • Results of Extraordinary General Meeting

    17 August 2021

  • Notice of Extraordinary General Meeting

    9 July 2021

  • Change of Director's Interest Notice - A Gray

    29 June 2021

  • Successful renewal of key contracts and new contract wins

    29 June 2021

  • Cleansing Notice

    25 June 2021

  • Application for quotation of securities - PKS

    25 June 2021

  • Release of Securities from Voluntary Escrow

    27 May 2021

  • Change of Director's Interest Notice - A Gray

    26 April 2021

  • Becoming a substantial holder

    26 April 2021

  • Change of Director's Interest Notice - S Borness

    26 April 2021

  • Cleansing Statement

    26 April 2021

  • Appendix 2A

    26 April 2021

Investor Presentations

Date

  • Annual General Meeting Addresses and Presentation

    24 November 2022

  • Half Year Results Investor Presentation

    15 February 2022

  • Investor Presentation to the AGM

    28 October 2021

  • Beamtree Potential (x) acquisition presentation

    31 August 2021

  • PKS Investor Presentation 2021

    27 August 2021

  • Capital raise and 1H FY21 results – Investor Presentation

    27 August 2021

  • PKS Investor Presentation 2020

    28 August 2020

Shareholder information

Share registry

Automic Pty Ltd
Address: Level 5, 126 Phillip Street, Sydney NSW 2000
Phone: 1300 288 664
Email: hello@automicgroup.com.au

Investor Queries

For all investor queries, please email investor@beamtree.com.au.

See all releases also on the ASX

Explore announcements